Reaction: Ribociclib to 1 product

Reaction
Ribociclib
DB11730
LEQ-803
DBMET03788
Reaction type
oxidation
Direction
Major circulating metabolite?
No
Spontaneous?
No
Activity
unknown
References
  1. FDA Approved Drug Products: Kisqali (ribociclib) tablets for oral use (September 2024) [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Cytochrome P450 3A4Not AvailableNot Availableconfirmed